日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Personalizing non-small cell lung cancer treatment through patient-derived xenograft models: preclinical and clinical factors for consideration

利用患者来源的异种移植模型实现非小细胞肺癌的个体化治疗:需要考虑的临床前和临床因素

Vered Fuchs # ,Ariel Sobarzo # ,Maha Msamra ,Yarden Kezerle ,Liat Linde ,Gur Sevillya ,Alaa Anoze ,Yael Refaely ,Ahron Yehonatan Cohen ,Israel Melamed ,Amit Azriel ,Rami Shoukrun ,Yael Raviv ,Angel Porgador ,Nir Peled ,Laila Catalina Roisman

Rapid Response to the Combination of Lenvatinib and Pembrolizumab in Patients with Advanced Carcinomas (Lung Adenocarcinoma and Malignant Pleural Mesothelioma)

晚期癌症患者(肺腺癌和恶性胸膜间皮瘤)对仑伐替尼和派姆单抗联合治疗的快速反应

Walid Shalata, Muhammed Iraqi, Baisali Bhattacharya, Vered Fuchs, Laila C Roisman, Ahron Yehonatan Cohen, Ismaell Massalha, Alexander Yakobson, Manu Prasad, Moshe Elkabets, Angel Porgador, Nir Peled